Q4 2023 VolitionRX Ltd Earnings Call Transcript

Mar 26, 2024 / 12:30PM GMT
Operator

Good morning, ladies and gentlemen, and thank you for standing by and welcome to VolitionRx Limited Fourth Quarter and Full Year 2023 earnings conference call. (Operator Instructions) This conference call is being recorded today March 26th, 2024.

I would now like to turn the conference over to Louise Batchelor, Group Chief Marketing and Communications Officer. Please go ahead.

Louise Batchelor - VolitionRX Ltd - Chief Marketing and Communications Officer

Thank you, and welcome, everyone to today's analyst conference call for Volition Rx Limited. Before we begin, I'd like to remind everyone that some of the information discussed on this conference call will include forward-looking statements covered under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on our beliefs as well as assumptions we have used based upon information currently available to us Because these statements reflect our current views concerning future events. These statements involve risks, uncertainties and assumptions.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot